Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2018 1
2019 1
2020 3
2022 1
2023 1
2024 2
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
Keech C, Miller VE, Rizzardi B, Hoyle C, Pryor MJ, Ferrand J, Solovay K, Thalen M, Noviello S, Goldstein P, Gorringe A, Cavell B, He Q, Barkoff AM, Rubin K, Locht C. Keech C, et al. Among authors: rubin k. Lancet. 2023 Mar 11;401(10379):843-855. doi: 10.1016/S0140-6736(22)02644-7. Lancet. 2023. PMID: 36906345 Clinical Trial.
Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant.
Liu Y, Freeborn J, Okeugo B, Armbrister SA, Saleh ZM, Fadhel Alvarez AB, Hoang TK, Park ES, Lindsey JW, Rapini RP, Glazer S, Rubin K, Rhoads JM. Liu Y, et al. Among authors: rubin k. Front Immunol. 2024 Oct 10;15:1469424. doi: 10.3389/fimmu.2024.1469424. eCollection 2024. Front Immunol. 2024. PMID: 39450167 Free PMC article.
Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.
Lin A, Apostolovic D, Jahnmatz M, Liang F, Ols S, Tecleab T, Wu C, van Hage M, Solovay K, Rubin K, Locht C, Thorstensson R, Thalen M, Loré K. Lin A, et al. Among authors: rubin k. J Clin Invest. 2020 May 1;130(5):2332-2346. doi: 10.1172/JCI135020. J Clin Invest. 2020. PMID: 31945015 Free PMC article. Clinical Trial.
Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis.
Gbesemete D, Ramasamy MN, Ibrahim M, Hill AR, Raud L, Ferreira DM, Guy J, Dale AP, Laver JR, Coutinho T, Faust SN, Reed TAN, Babbage G, Weissfeld L, Lang W, Locht C, Samal V, Goldstein P, Solovay K, Rubin K, Noviello S, Read RC. Gbesemete D, et al. Among authors: rubin k. Lancet Microbe. 2025 Dec;6(12):101211. doi: 10.1016/j.lanmic.2025.101211. Epub 2025 Dec 1. Lancet Microbe. 2025. PMID: 41344352 Free article. Clinical Trial.
14 results